​

Relmada Therapeutics Ownership | Who Owns Relmada Therapeutics?

OverviewForecastFinancialsChartTranscripts

Relmada Therapeutics Ownership Summary

Relmada Therapeutics is owned by 19.82% institutional investors, 2.90% insiders, and 77.27% retail investors. Janus henderson group is the largest institutional shareholder, holding 28.02% of RLMD shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.57% of its assets in Relmada Therapeutics shares.

RLMD Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockRelmada Therapeutics19.82%2.90%77.27%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%
IdeaPsychedelic Stocks List14.03%7.77%78.20%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group11.06M28.02%$76.89M
Vr adviser4.84M12.27%$33.71M
Adage capital partners gp4.76M12.06%$33.15M
Orbimed advisors4.72M11.95%$32.82M
Marshall wace, llp4.48M11.35%$31.19M
Millennium management3.91M9.90%$27.19M
Ra capital management2.95M7.47%$20.51M
Ikarian capital2.69M6.81%$18.71M
Driehaus capital management2.13M5.40%$14.84M
Vanguard group1.20M3.63%$5.81M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Knott david m jr439.30K1.82%$3.06M
Birchview capital, lp409.39K1.62%$2.85M
Ikarian capital2.69M1.52%$18.71M
Great point partners842.11K1.35%$5.86M
Vr adviser4.84M1.26%$33.71M
Sio capital management965.00K0.96%$6.72M
Opaleye management935.00K0.86%$6.51M
Stempoint capital lp597.41K0.81%$4.16M
Boxer capital management842.11K0.77%$5.86M
Orbimed advisors4.72M0.65%$32.82M

Top Buyers

HolderShares% AssetsChange
Vr adviser4.84M1.26%4.84M
Janus henderson group11.06M0.04%3.79M
Ra capital management2.95M0.22%2.95M
Millennium management3.91M0.01%2.23M
Orbimed advisors4.72M0.65%2.11M

Top Sellers

HolderShares% AssetsChange
Braidwell lp---1.58M
Ameriprise financial533.26K0.00%-1.39M
Deep track capital, lp---674.83K
Palo alto investors lp---495.15K
Vestal point capital, lp---490.00K

New Positions

HolderShares% AssetsChangeValue
Vr adviser4.84M1.26%4.84M$33.71M
Ra capital management2.95M0.22%2.95M$20.51M
Polar capital1.41M0.04%1.41M$9.85M
Sio capital management965.00K0.96%965.00K$6.72M
Soleus capital management842.11K0.24%842.11K$5.86M

Sold Out

HolderChange
Blackston financial advisory group-2.00
Innealta capital-5.00
Smartleaf asset management-35.00
Larson financial group-100.00
Massmutual trust co fsb/adv-113.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202636-57.14%7,826,692-84.63%190.08%20-63.64%6-45.45%
Dec 31, 202543-4.44%13,954,17380.30%427.73%2237.50%8-27.27%
Sep 30, 202544-8.33%7,739,57845.94%239.13%16-5.88%10-23.08%
Jun 30, 2025476.82%5,303,149-14.73%153.82%1741.67%12-14.29%
Mar 31, 202544-15.38%6,219,493-25.95%202.64%12-36.84%14-33.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF851.92K2.57%-
Vanguard Total Stock Mkt Idx Inv2.18M2.08%-
Franklin Biotechnology Discv A(acc)USD623.80K2.07%-221.90K
Polar Capital Biotech S Inc1.34M1.28%-
Biotech Growth Ord1.31M1.25%-
Franklin Biotechnology Discovery A336.31K1.11%-120.09K
Vanguard Institutional Extnd Mkt Idx Tr829.41K0.79%3.99K
Horizons Psychedelic Stock ETF227.04K0.75%-36.13K
AdvisorShares Psychedelics ETF383.91K0.37%5.86K
Fidelity Extended Market Index379.03K0.36%47.19K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 15, 2025TRAVERSA SERGIO Chief Executive OfficerBuy$113.30K
Dec 15, 2025Shenouda Maged Chief Financial OfficerBuy$48.06K
Nov 05, 2025Shenouda Maged Chief Financial OfficerBuy$1.10M
Nov 05, 2025Ence Chuck CAO and COOBuy$299.20K
Nov 05, 2025TRAVERSA SERGIO Chief Executive OfficerBuy$599.50K

Insider Transactions Trends

DateBuySell
2025 Q46-
2025 Q33-
2025 Q28-
2024 Q4--
2024 Q38-

RLMD Ownership FAQ

Who Owns Relmada Therapeutics?

Relmada Therapeutics shareholders are primarily institutional investors at 19.82%, followed by 2.90% insiders and 77.28% retail investors. The average institutional ownership in Relmada Therapeutics's industry, Biotech Stocks , is 35.75%, which Relmada Therapeutics falls below.

Who owns the most shares of Relmada Therapeutics?

Relmada Therapeutics’s largest shareholders are Janus henderson group (11.06M shares, 28.02%), Vr adviser (4.84M shares, 12.27%), and Adage capital partners gp (4.76M shares, 12.06%). Together, they hold 52.36% of Relmada Therapeutics’s total shares outstanding.

Does Blackrock own Relmada Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Relmada Therapeutics.

Who is Relmada Therapeutics’s biggest shareholder by percentage of total assets invested?

Knott david m jr is Relmada Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.82% of its assets in 439.3K Relmada Therapeutics shares, valued at 3.06M$.

Who is the top mutual fund holder of Relmada Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Relmada Therapeutics shares, with 2.57% of its total shares outstanding invested in 851.92K Relmada Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools